Similarly, the administration of EGFR inhibitors AG1478 and Gefitinib led to a reduction in cell proliferation, decreased invasion, and enhanced apoptosis in HCC cells [38,45]. This evidence concerns the gene EGFR and hepatocellular carcinoma.